NeoStem
420 Lexington Avenue
Suite 350
New York, New York 10170
Telephone: 1.212.584.4180

Media Coverage

November 17, 2014

Dr. Arshed Quyyum interviewed at American Heart Association Scientific Sessions

Dr. Arshed Quyyum, MD, FACC, Professor of Medicine at Emory University and Lead Principal Investigator of NeoStem’s PreSERVE AMI clinical study, discusses data released from trial at the American Heart Association's Scientific Sessions.


October 13, 2014

NeoStem Acquires Its Way to the Top

Dr. Robin Smith, CEO of NeoStem, discusses how the acquisition of six biotech companies has enabled her to find talent in the emerging industry of cell therapy.


August 12, 2014

Finance Monthly Interview of Dr. Robin L. Smith

Finance Monthly interviews NeoStem CEO Dr. Robin L. Smith about current programs and what the future might hold.


July 15, 2014

Dr. Robin Smith featured on Taking Stock, Bloomberg Radio

Dr. Robin Smith discusses NeoStem and its platform technologies with Pimm Fox, anchor of Taking Stock on Bloomberg Radio.

© 2014 Bloomberg L.P. All rights reserved. Used with permission.


July 14, 2014

Dr. Robin Smith’s M&A tips and insights in Investors Business Daily

Dr. Robin Smith shares tip and insight with Investors Business Daily shares about increasing a company's value through M&A.


June 20, 2014

Drug Discovery News profiles NeoStem’s leadership in cellular therapy

Dr. Robin Smith spoke with Drug Discovery News about NeoStem's new Targeted Immunotherapy Program and its expected launch of a Phase 3 trial for metastatic melanoma.


June 20, 2014

Dr. Robin Smith’s Editorial in MediaPlanet Focuses on Targeting Cancer with Immunotherapies

Dr. Robin Smith speaks on the powerful potential of cell-based therapies to change how we treat advanced cancer.


April 16, 2014

Dr. Robin Smith speaks with The Deal Pipeline

Dr. Robin Smith spoke with Michael Brown of The Deal about NeoStem's strategic acquisition of California Stem Cell, Inc.


April 16, 2014

NeoStem adds facility with $124M California Stem Cell acquisition

Dr. Robin Smith and Dr. Hans Keirstead spoke to BioPharma-Reporter.com about NeoStem's acquisition of California Stem Cell.


April 14, 2014

Irvine stem cell drugmaker sold for $126 million

The Orange County Record looked at the acquisition of the Irvine based California Stem Cell by NeoStem by interviewing both Dr. Hans Keirstead and Dr. Robin Smith.


April 14, 2014

NeoStem to acquire California Stem Cell, expanding pipeline

The Pharma Letter looks in-depth at the NeoStem definitive agreement to acquire California Stem Cell.


April 14, 2014

NeoStem to Acquire CSC in Potential $124M-Plus Stem Cell Deal

Genetic Engineering & Biotechnology News covers NeoStem's acquisition of California Stem Cell.


February 12, 2014

Dr. Robin Smith featured for second interview on the Traders Network

Dr. Robin Smith was featured live for a second time on Clear Channel's "the Traders Network" DFW 1190AM radio broadcast hosted by Michael Yorba. Read the press release and listen to the broadcast archive.


December 5, 2013

Dr. Robin Smith featured on the Traders Network

Dr. Robin Smith was featured live on Clear Channel's "the Traders Network" DFW 1190AM radio broadcast hosted by Michael Yorba. Read the press release and listen to the broadcast archive.


November 7, 2013

NeoStem featured in Life Science Leader magazine

Dr. Robin Smith was interviewed in the November issue of Life Science Leader magazine in which she discussed the Company's future development and its innovative relationship with the Vatican.


October 29, 2013

NeoStem in BioTuesdays.com

On October 29, 2013, NeoStem was profiled on BioTuesdays.com. Dr. Robin Smith spoke about the company and its lead product candidate AMR-001.


October 25, 2013

Dr. Robin Smith featured in the Huffington Post: Women in Business

On October 25, 2013, Dr. Robin Smith was interviewed by The Huffington Post for its Women in Business feature.


September 20, 2013

Neostem: Helping to Treat Disease With Stem Cells, Dr. Robin L. Smith, Appears on Bloomberg TV

On September 20, 2013, Dr. Robin Smith discusses cell therapies that use the body’s own cells to help a patient recover from disease with Pimm Fox on Bloomberg Television’s “Taking Stock.”


September 13, 2013

Dr. Robin Smith Interviewed in The Wall Street Transcript

On September 13, 2013, The Wall Street Transcript published an interview with NeoStem’s Chairman and CEO, Dr. Robin Smith, who presented an overview of the company’s value proposition.


August 22, 2013

RedChip Money Report on NeoStem

On August 22, 2013, Dr. Robin Smith, Chairman and CEO of NeoStem, joins RedChip's Thomas Pfister to discuss NasdaqCM: NBS and why being on NASDAQ puts NeoStem in a better position to enhance the investor base towards institutions and spread understanding of the paradigm shift towards regenerative medicine.


August 7, 2013

Dr. Robin Smith on the NASDAQ CEO Signature Series

On August 7, 2013, Dr. Robin L. Smith, Chairman and CEO of Neostem, sat with Carmen Roberts for an interview on topic of NeoStem's move from the NYSE to NASDAQ and on the future of the company. She discussed NeoStem's relationship with the Vatican, recent additions to management, and PreSERVE Phase 2 trial for the preservation of heart muscle function after a severe heart attack.


August 5, 2013

NeoStem speaks with The Deal Pipeline

Michael Brown from The Deal Pipeline interviewed Dr. Robin Smith about its move to Nasdaq and recent news.


NeoStem_Appear-on-Bloom
March 21, 2013

NeoStem CEO, Dr. Robin L. Smith and Msgr. Tomasz Trafny, Appear on Bloomberg TV

Dr. Robin Smith and Monsignor Tomasz Trafny from the Vatican's Pontifical Council for Culture discuss the Vatican's role in scientific advancements with Alix Steel on Bloomberg Television's "Taking Stock".


Forbes Logo
May 14, 2012

Catholic Church Declares Support For Adult Stem Cell Research

Steven Myers, a director of NeoStem, discusses the First International Adult Stem Cell Conference held in Vatican City, November 9-11, 2011, co-hosted by NeoStem.


Neostem CEO - Dr. Robin L. Smith
May 14, 2012

NeoStem CEO, Dr. Robin L. Smith, Appears on Bloomberg TV

On Monday, May 14, 2012 Dr. Robin L. Smith, spoke with Pimm Fox, host of Bloomberg Television's "Taking Stock", about NeoStem and the company's PreSERVE clinical trial.


amorcyte orlando foxz
March 14, 2012

News Orlando FOX story on Amorcyte’s AMR-001

News Orlando FOX story on Orlando Regional Medical Center using Amorcyte’s AMR-001 Phase 2 trial to preserve heart function after a heart attack with bone-marrow derived stem cells.


build-the-heart
December 6, 2011

CBS New York Story on Amorcyte Phase I Clinical Trial

CBS New York story on Amorcyte’s Phase 1 trial results in repairing the heart after a heart attack with bone-marrow derived stem cells.


Pope Benedict Image
November 23, 2011

HealthWatch: Adult Stem Cells And The Catholic Church

NEW YORK (CBSNewYork) - At a recent conference on stem cells endorsed by and held at the Vatican, Pope Benedict XVI announced the Catholic Church’s support for adult stem cell research.


NeoStem - Cell Therapy Development - Media Section